DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Go back to DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows
Illumina, Inc. (NASDAQ: ILMN) Delayed: 161.93 +2.84 (1.79%)
Previous Close $159.09    52 Week High $196.47 
Open $161.31    52 Week Low $127.10 
Day High $162.78    P/E 179.92 
Day Low $159.51    EPS $0.90 
Volume 3,100,677